Account

Background Heartbeat

Medical Cannabis Insurance in South Africa: What Schemes Pay

Medical cannabis insurance paperwork being signed at a desk in South Africa

Medical cannabis insurance in South Africa rarely works the way patients expect. Medical schemes are not obliged to pay for a cannabis medicine simply because a doctor prescribed it, because almost every cannabis product prescribed here is unregistered and reaches the patient through a SAHPRA Section 21 authorisation rather than through a scheme formulary. Most members end up paying from a medical savings account or out of their own pocket. Cover, where it exists at all, is decided by your scheme rules, your diagnosis and your paperwork.

Last updated:

Key takeaways

  • A medical scheme and a health insurance policy are two different products under two different laws. Only one of them is designed to reimburse the cost of medicine, and confusing them is the most common medical cannabis insurance mistake.
  • Prescribed Minimum Benefits force your scheme to cover the diagnosis, treatment and care of a listed condition. They do not force it to cover a specific product, and where there is a dispute the public sector protocols apply.
  • Cannabis medicines containing THC are Schedule 6 and are usually unregistered, so they are accessed through a named patient Section 21 authorisation. Unregistered medicines normally sit outside a scheme formulary.
  • Your prescription, the Section 21 authorisation letter, the ICD-10 diagnosis code and a proper pharmacy invoice are what a claims assessor actually reads. Missing one of them is a far more common reason for a rejection than the medicine itself.
  • If your scheme refuses, you must exhaust its internal dispute process first, then take the matter to the Council for Medical Schemes.

Working out the funding side while you research the access side? You can create your Professor Green account and come back to this page. Registration starts the access process. A registered doctor decides what is clinically appropriate, and your scheme decides separately what it will pay.

Why medical cannabis insurance works differently in South Africa

Two entirely different products get called cover in ordinary conversation, and the difference decides whether a cannabis prescription can ever be reimbursed. A medical scheme is registered and regulated under the Medical Schemes Act 131 of 1998 and supervised by the Council for Medical Schemes. In exchange for a monthly contribution, it pays for healthcare you need, including doctor visits, hospital accommodation and medicine. A health insurance policy is a different animal. The Council describes it as cover that pays out when a specified health related event happens, often as a fixed sum per day in hospital or a lump sum on diagnosis, and it does not pay your medical expenses the way a scheme does.

That distinction is where most medical cannabis insurance questions actually get answered. A hospital cash plan that pays a fixed amount for each day you are admitted will not reimburse a bottle of prescribed cannabis oil collected from a pharmacy, no matter how well documented the prescription is, because reimbursing medicine is not what the product does. A registered medical scheme option might, but only within its own rules, its formulary and its benefit limits.

Two scheme rules catch new members in particular. A general waiting period of up to three months can be imposed when you move between schemes, during which you pay contributions but cannot claim. A condition specific waiting period of up to twelve months can be imposed on a pre-existing condition identified at application, during which the associated costs are for your own pocket. Prescribed Minimum Benefits are the exception to both, under sections 29A(3) and 29A(2) of the Act.

Doctor handing a patient a clipboard of documents needed for a medical cannabis insurance claim

What your medical scheme must cover, and what it may decline

Prescribed Minimum Benefits, or PMBs, are the legal floor. Every medical scheme must cover the diagnosis, treatment and care of any emergency medical condition, a defined set of about 271 conditions expressed as Diagnosis and Treatment Pairs, and 26 chronic conditions on the Chronic Disease List. The obligation holds even when a member’s day to day benefits for the year have run out. The legislation governing PMBs sits in the regulations made under the Medical Schemes Act 131 of 1998.

Read that carefully, because the obligation attaches to the condition, not to the product. The Council’s own guidance says treatment and care of PMB conditions should be based on healthcare that has proven to work best, taking affordability into account, and that where there is a disagreement about the treatment of a specific case, the standards, practices and protocols in force in the public sector apply. Cannabis medicines do not currently sit in South African public sector protocols for any PMB condition. A scheme can therefore satisfy its PMB duty by funding a conventional medicine on its formulary and decline the cannabis product, without breaking the law.

This is not a reason to give up on the claim. It is a reason to stop arguing the wrong point. A PMB argument that says “you must pay for this because my condition is a PMB” will lose. A benefit argument that says “my option includes a medical savings account and this is a valid prescribed medicine dispensed by a licensed pharmacy, so please pay it from my savings” is a different question entirely, and it is usually the one worth asking first.

Before you start

In South Africa, medical cannabis containing THC is prescription-only through a registered doctor, usually via a SAHPRA Section 21 authorisation. This is general information for adults 18 and over, not medical advice and not financial or legal advice. Do not stop or change a treatment your scheme already funds in order to try something else. Speak to a doctor or pharmacist before starting, stopping or changing any treatment, especially about dosing, and confirm any benefit question directly with your own scheme.

Why most cannabis prescriptions fall outside scheme cover

The scheduling position explains most of it. SAHPRA’s communication to industry on the scheduling status of THC and CBD, issued under Government Notice 586 in Government Gazette 43347 on 22 May 2020, places THC in Schedule 6 with narrow exceptions, and CBD in Schedule 4 except for two carve outs. Those carve outs are complementary medicines containing no more than 600 mg of CBD per sales pack with a maximum daily dose of 20 mg making only a low risk claim, and ingested processed products containing 0,0075 percent or less CBD, both of which fall to Schedule 0.

A Schedule 6 medicine needs a prescription. On top of that, the specific cannabis product is usually not registered with SAHPRA, which is why the prescriber applies under section 21 of the Medicines and Related Substances Act 101 of 1965 for authorisation to access an unregistered medicine for a named patient. That authorisation is a regulatory permission to supply one patient. It is not a funding decision, and it does not bind your scheme in any way.

From a claims assessor’s chair, an unregistered named patient medicine is an awkward object. It typically has no place on the scheme formulary, it may not map neatly onto the reimbursement codes their system expects, and there is no registered package insert for them to check the indication against. None of that makes payment impossible, but it does mean the claim will be looked at by a human rather than paid automatically, and it means you should ask before you spend rather than after.

Ask your scheme thisWhy it decides the outcome
Does my option include a medical savings account, and what is left in it?A savings account is the route that most often pays for a prescribed cannabis medicine, because it is your money allocated to healthcare rather than a risk benefit decision.
Will you fund an unregistered medicine supplied under a SAHPRA Section 21 authorisation?This is the single question that determines whether a risk benefit claim is even possible. Get the answer in writing with a reference number.
Do you require pre-authorisation, and what must the application contain?A claim submitted without a required pre-authorisation is normally rejected on process alone, before anyone considers the clinical merits.
Is my condition on the Chronic Disease List or a Diagnosis and Treatment Pair?It changes what the scheme must fund for the condition overall, even if it does not force cover of the cannabis product itself.
Am I inside a general or condition specific waiting period?Up to three months general and up to twelve months condition specific, with PMBs as the exception. Claiming inside one wastes the attempt.
Which pharmacy or provider must dispense for the claim to be paid?Designated service provider rules can reduce or void payment when the medicine is obtained elsewhere, even when everything else is correct.

The documents that decide a medical cannabis insurance claim

Claims are assessed on paper. In practice a medical cannabis insurance claim in South Africa is judged on six things, and you can assemble all of them before you spend a cent.

  • A valid prescription from a doctor registered with the Health Professions Council of South Africa, naming the product, its form, its strength and the quantity.
  • The SAHPRA Section 21 authorisation letter for you as a named patient, where the product is unregistered.
  • The ICD-10 diagnosis code, which must match the clinical record and appear on the pharmacy account.
  • A tax invoice from the licensed dispensing pharmacy showing its details, the product dispensed and the amount charged.
  • Clinical notes showing what was tried before, and for how long, because motivations that show a treatment history are assessed differently from a first line request.
  • Your scheme’s pre-authorisation reference, where one was required.

Ask your prescriber for a copy of everything at the consultation rather than chasing it weeks later. If you want the underlying legal picture on how a Section 21 approval is worded and what it actually permits, our guide to what a Section 21 yes actually covers goes through it line by line, and our piece on getting a copy of your own health record explains how to obtain the clinical notes a claim assessor will ask for.

Pharmacy counter where a prescribed medical cannabis invoice is issued for a scheme claim

How Professor Green fits into the process

Professor Green is a South African medical cannabis platform. Registering creates your account and begins the access process, which is where the paperwork above starts to exist. It is worth being precise about who does what, because the divisions matter to a claim.

  • A registered doctor assesses you, decides whether cannabis is clinically appropriate at all, and writes any prescription. Professor Green does not make that decision and cannot make it for you.
  • SAHPRA grants any Section 21 authorisation for an unregistered medicine, on the prescriber’s application.
  • A licensed pharmacy dispenses the medicine and issues the invoice your scheme will read.
  • Your medical scheme decides, independently of everyone above, what it will pay and from which benefit.
  • Professor Green connects you to that prescriber led route and lists the products in the catalogue, so you can quote an exact product name, form and strength when you phone your scheme. Individual product pages such as Femme Fatale show the detail a pre-authorisation form asks for.

Registration does not create cover, guarantee eligibility, guarantee supply, or oblige any scheme to pay anything. It is the first step in the access journey and nothing more than that.

If you have worked out what your scheme will and will not do and want to understand the legal access route properly, register for Professor Green store access. Registration creates your account and begins the process. A registered doctor decides what, if anything, is clinically appropriate, and funding remains a separate conversation with your scheme.

If your scheme refuses to pay

A rejection is not the end of the road, but the order of the steps is not optional. Start by asking the scheme for its reasons in writing, along with the clause in the scheme rules it is relying on. Then use the scheme’s own internal dispute resolution process. The Council for Medical Schemes is explicit that complainants must first exhaust internal dispute resolution at the scheme or regulated entity before approaching the Council.

If the internal escalation fails, any person aggrieved by the conduct of an entity registered or accredited under the Medical Schemes Act may lodge a complaint with the Council. A complaint is treated as valid where the entity is alleged to have acted, or failed to act, in contravention of the Act, or to have acted improperly on a matter within the Council’s jurisdiction. The Council asks for a completed complaint form with a detailed account of the facts and the recourse you want, proof of the prior escalation, a signed letter of consent where a third party is complaining for the member, all relevant clinical reports where the dispute has a clinical element, and account statements where the dispute is about unpaid or short paid claims. Complainants are encouraged to come forward as soon as they cannot reach a resolution, preferably within three years.

Keep a contemporaneous record of every call: the date, the consultant’s name and the reference number. Schemes work from their own file notes, and a member who can quote a reference number from four months ago is in a materially stronger position than one who cannot. The same discipline about record keeping applies at the clinical end, which our guide to what you have to declare covers in more detail.

Frequently asked questions about medical cannabis insurance

Does any South African medical scheme cover medical cannabis?
There is no blanket answer, because cover is set option by option in each scheme’s registered rules rather than nationally. What is consistent is that cannabis medicines are usually unregistered and supplied under a Section 21 authorisation, which places them outside most formularies. Ask your own scheme in writing before you assume either way.

Can my medical savings account pay for a cannabis prescription?
A medical savings account is the route that most often works, because it is your own allocated funds rather than a risk benefit. It still depends on your scheme’s rules and on the claim being submitted correctly by a licensed dispensing pharmacy. Confirm it with your scheme first.

My condition is a Prescribed Minimum Benefit. Does that force cover?
It forces cover of the diagnosis, treatment and care of the condition. It does not force cover of one specific product. Where there is a disagreement about treatment in a specific case, the practices and protocols in force in the public sector are applied, and cannabis medicines are not part of those protocols.

Will a hospital plan or health insurance policy reimburse my prescription?
Generally no. The Council for Medical Schemes describes health insurance as cover that pays a fixed daily amount or a lump sum when a specified event occurs, rather than paying your medical expenses. Reimbursing outpatient medicine is not what that product is built to do.

Does a SAHPRA Section 21 authorisation mean my scheme has to pay?
No. A Section 21 authorisation is a regulatory permission for a named patient to be supplied with an unregistered medicine. It says nothing about funding and creates no obligation on a medical scheme.

Do I need a pre-authorisation before I collect the medicine?
Often yes, and this is the most avoidable reason a medical cannabis insurance claim fails. Phone the scheme, ask whether pre-authorisation is required for the specific product, and record the reference number before the pharmacy dispenses.

What if I have just joined a new scheme?
Check your waiting periods first. A general waiting period of up to three months and a condition specific waiting period of up to twelve months may apply, with Prescribed Minimum Benefits as the statutory exception. Claiming inside a waiting period simply wastes the attempt.

How long do I have to complain about a rejected claim?
The Council for Medical Schemes encourages complainants to come forward as soon as they are unable to reach a resolution with the scheme, preferably within a three year period, and only after the scheme’s internal dispute process has been exhausted.

The honest bottom line on medical cannabis insurance

Medical cannabis insurance in South Africa is a funding question, not a legal access question, and the two get tangled constantly. Legal access runs through a registered doctor and, where the product is unregistered, a SAHPRA Section 21 authorisation. Funding runs through your scheme’s registered rules, your benefit option and, most often, your medical savings account. Nobody at SAHPRA or at your prescriber’s rooms can make your scheme pay, and no amount of clinical justification substitutes for a pre-authorisation reference number and a correctly coded pharmacy invoice. Plan for the cost, ask the six questions in the table above before you spend, and keep every piece of paper.

Get legal medical cannabis access in South Africa

If you have been researching medical cannabis insurance and want to understand the prescriber led access route rather than the marketing, the next step is to create your account. Registration begins the process. A registered doctor decides what, if anything, is clinically appropriate for you, and your medical scheme decides separately what it will fund.

Register for Store Access

Sources and References

Every legal and regulatory claim on this page traces to one of the following sources, each checked before publication.

Share the Post:

Related Posts

Professorgreen.co.za is ran by Green Tec LLC is an authorised marketing affiliate for the Dr Green network who holds the Medical Cannabis licences in South Africa. We do not sell, handle, or ship cannabis. All cannabis products are sold and fulfilled by licensed operator DR Green.

Our Social